Bulletin
Investor Alert

Tilray Inc. Cl 2

NAS: TLRY

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Apr 9, 2021, 7:59 p.m.

/zigman2/quotes/209129655/composite

$

19.84

Change

+0.08 +0.40%

Volume

Volume 90,803

Quotes are delayed by 20 min

/zigman2/quotes/209129655/composite

Previous close

$ 19.77

$ 19.76

Change

-0.01 -0.05%

Day low

Day high

$19.40

$20.68

Open

52 week low

52 week high

$4.41

$67.00

Open

Insider Actions for Tilray Inc. Cl 2

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
04/01/2021 Michael B. Shtender-Auerbach
Director
2,188   Derivative/Non-derivative trans. at $0 per share. 0
03/18/2021 Andrew Pucher
Chief Corporate Dev Officer
3,495   Derivative/Non-derivative trans. at $0 per share. 0
03/18/2021 Andrew Pucher
Chief Corporate Dev Officer
7,497   Derivative/Non-derivative trans. at $0 per share. 0
03/16/2021 Michael B. Shtender-Auerbach
Director
31,164   0
03/16/2021 Michael B. Shtender-Auerbach
Director
73,593   0
03/16/2021 Michael B. Shtender-Auerbach
Director
268,095   0
03/16/2021 Michael B. Shtender-Auerbach
Director
685,424   0
03/05/2021 Michael Kruteck
Chief Financial Officer
14,646   Derivative/Non-derivative trans. at $0 per share. 0
03/05/2021 Jon Levin
Chief Operating Officer
15,830   Derivative/Non-derivative trans. at $0 per share. 0
03/05/2021 Michael Kruteck
Chief Financial Officer
33,360   Award at $0 per share. 0
03/05/2021 Jon Levin
Chief Operating Officer
33,360   Award at $0 per share. 0
03/01/2021 Rebekah Dopp
Director
2,187   Derivative/Non-derivative trans. at $0 per share. 0
03/01/2021 Christine Thompson St. Clare
Director
2,187   Derivative/Non-derivative trans. at $0 per share. 0
02/23/2021 Michael B. Shtender-Auerbach
Director
5,929   0
02/23/2021 Michael B. Shtender-Auerbach
Director
20,392   0
02/23/2021 Michael B. Shtender-Auerbach
Director
89,349   0
02/23/2021 Michael B. Shtender-Auerbach
Director
228,433   0
02/19/2021 Michael Kruteck
Chief Financial Officer
23,476   Derivative/Non-derivative trans. at $0 per share. 0
02/19/2021 Jon Levin
Chief Operating Officer
26,982   Derivative/Non-derivative trans. at $0 per share. 0
02/19/2021 Michael Kruteck
Chief Financial Officer
53,191   Award at $0 per share. 0
02/19/2021 Jon Levin
Chief Operating Officer
56,738   Award at $0 per share. 0
01/25/2021 Brendan Kennedy
President and CEO; Director
57   0
01/25/2021 Brendan Kennedy
President and CEO; Director
3,371   0
01/25/2021 Michael B. Shtender-Auerbach
Director
202   0
01/25/2021 Michael B. Shtender-Auerbach
Director
517   0
01/25/2021 Michael B. Shtender-Auerbach
Director
116   0
01/01/2021 Brendan Kennedy
President and CEO; Director
12,777   Derivative/Non-derivative trans. at $0 per share. 0
01/01/2021 Brendan Kennedy
President and CEO; Director
46,875   Derivative/Non-derivative trans. at $0 per share. 0
01/01/2021 Michael B. Shtender-Auerbach
Director
2,187   Derivative/Non-derivative trans. at $0 per share. 0
12/18/2020 Michael B. Shtender-Auerbach
Director
3,595   0
12/18/2020 Michael B. Shtender-Auerbach
Director
13,895   0
12/18/2020 Andrew Pucher
Chief Corporate Dev Officer
7,497   Derivative/Non-derivative trans. at $0 per share. 0
12/18/2020 Michael B. Shtender-Auerbach
Director
61,289   0
12/18/2020 Michael B. Shtender-Auerbach
Director
156,693   0
12/18/2020 Andrew Pucher
Chief Corporate Dev Officer
3,303   Derivative/Non-derivative trans. at $0 per share. 0

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
12 Purchases
14 Sales
321,786
1,359,993
Last 6 months
20 Purchases
30 Sales
780,992
3,605,467
Last 12 months
49 Purchases
56 Sales
9,730,629
7,189,073

Officers and Executives

Mr. Brendan Kennedy
President, Chief Executive Officer & Director
Mr. Jon Levin
Chief Operating Officer
Mr. Michael Kruteck
Chief Financial Officer
Dr. Joshua Eades
Chief Science Officer & Vice President
Mr. Michael Auerbach
Director
Ms. Rita Seguin
Chief Human Resources Officer
Ms. Dara Redler
Secretary & General Counsel
Ms. Catherine Jacobson
VP-Regulatory & Medical Affairs
Mr. Soren W. Schroder
Independent Director
Ms. Christine Thompson St. Clare
Independent Director
Ms. Rebekah Dopp
Independent Director
Mr. Michael B. Shtender-Auerbach
Independent Director
Trending Tickers
  • /quotes/zigman/17636479/composite VUZI+15.60%
  • /quotes/zigman/237947/composite JCP-5.83%
  • /quotes/zigman/59392505/composite NUGT-2.93%
  • /quotes/zigman/59386294/composite JNUG-5.94%
  • /quotes/zigman/65801738/composite TLT+1.11%
X
Powered by StockTwits
Link to MarketWatch's Slice.